Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacy

  • 0Molecular Psychiatry Laboratory, Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.

|

|

Summary

This summary is machine-generated.

Antipsychotic drugs alter gene expression in rat brains. Common changes in 154 genes suggest a role for altered gene expression in the therapeutic effects of these medications.

Area Of Science

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background

  • Antipsychotic drugs are believed to exert therapeutic effects through molecular changes.
  • Previous studies indicate antipsychotic treatment alters gene expression in the rat cortex.

Purpose Of The Study

  • To identify common gene expression changes induced by two antipsychotic drugs.
  • To investigate the relationship between these molecular alterations and therapeutic mechanisms.

Main Methods

  • Rat cortical RNA levels were measured using Affymetrix GeneChip® Rat Genome 230 2.0 Arrays.
  • Animals received vehicle, haloperidol, or chlorpromazine in drinking water for 28 days (n=10 per group).
  • Panther Gene Ontology Classification System was employed to analyze biological consequences of gene expression changes.

Main Results

  • Chlorpromazine and haloperidol treatments altered cortical RNA levels in 454 and 102 genes, respectively, compared to vehicle controls.
  • A significant overlap was observed, with 154 genes showing highly correlated fold changes in expression after treatment with both drugs (p < 0.05).
  • Affected genes included enzymes, receptors, signaling pathways, transcription regulators, cytoskeleton components, and transporters.

Conclusions

  • Altered gene expression is a significant mechanism of action for antipsychotic drugs.
  • Specific gene expression changes identified in this study may contribute to the therapeutic benefits of antipsychotic medications.

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents 01:21

326

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

Psychosis: Goals of Pharmacotherapy 01:26

212

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Psychosis and Antipsychotic Drugs: Overview 01:28

463

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders 01:27

993

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...